Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
China
Xinjiang Uygur Autonomous Region Center for Disease Control and Prevention, Xinjiang